Biochemical and Biophysical Research Communications
Mini ReviewRecent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy
Introduction
Diabetic nephropathy (DN) is a serious complication of diabetes mellitus, and its prevalence has been increasing worldwide. DN is the leading cause of end stage renal diseases worldwide [1]. DN is characterized by morphological and ultrastructural changes in the kidney including expansion of the molecular matrix and loss of the charge barrier on the glomerular basement membrane [2], [3]. DN is a multifactorial progressive disease where the pathogenesis of the disease is extremely complex involving many different cells, molecules, and factors [4]. The term diabetic nephropathy is used to describe the combination of lesions that often occur concurrently in the diabetic kidney. The most common kidney lesions in people with diabetes are those that affect the glomeruli. The pathogenesis of diabetic nephropathy is complex and still not fully elucidated. This review summarizes the recent advances in understanding the biochemical and molecular mechanism of DN.
Section snippets
Hyperglycemia
Hyperglycemia has generally been considered as the key initiator of kidney damage associated with DN by activation and dysregulation of several metabolic pathways. Hyperglycemia leads to an increase in oxidative stress by exacerbating glucose oxidation and mitochondrial generation of reactive oxygen species (ROS) which cause DNA damage and contributes to accelerated apoptosis [5]. Also increased ROS activate poly (ADP ribose) polymerase (PARP) as a reparative enzyme [6]. PARP inhibits
Advanced glycation end products (AGEs)
Increasing evidence demonstrates that AGEs play a pivotal role in the development and progression of diabetic vascular damage [8]. Further, diabetic patients with end-stage renal disease had almost twice as much AGEs in tissue as diabetic patients without renal disease [8]. Both enhanced formation and decreased clearance are responsible for the accumulation of AGEs in patients with diabetic nephropathy [9], [10]. Accumulation of AGEs in the kidney may contribute to the progressive alteration in
Protein kinase C
Among various signaling kinases, PKC seems to be a centerpiece in the pathogenesis of diabetic nephropathy [16]. Under high glucose ambience it is activated by diacylglycerol (DAG) formed during glycolytic intermediary steps and by ROS generated following AGE: RAGE interactions [17], [18]. Such interactions at the cell membrane activate PKC by increasing the activity of phospholipase C with an increase in intracellular Ca2+ and DAG. This cyclic generation of DAG would suggest an intimate ālevel
Oxidative stress
Increasing evidence in both experimental and clinical studies suggests that there is a close link between hyperglycemia, oxidative stress, and diabetic complications [20], [21]. High glucose induces intracellular ROS directly via glucose metabolism and auto-oxidation and indirectly through the formation of AGEs and their receptor binding [22]. ROS mimic the stimulatory effects of high glucose and upregulate TGF-beta1, PAI-1, and ECM proteins by glomerular mesangial cells, thus leading to
Inflammation
Recent evidence shows an increase in macrophage infiltration and overproduction of leukocyte adhesion molecules in kidneys from diabetic humans and in experimental animal models of diabetes [24], [25]. Chronic inflammation plays an important role in the development of diabetes and its late complications [25], [26], [27], [28]. Increasing evidence points to critical roles of pro-inflammatory cytokines in pathogenesis of diabetic nephropathy. For example, interleukin 1 (IL-1) is believed to
Poly(ADP-ribose) polymerase (PARP) activation
PPARĪ³ (peroxisome-proliferator-activated receptor Ī³) modulates numerous effectors of ECM accumulation [33]. TZDs (thiazolidinediones) are synthetic ligands of PPARĪ³, which is involved in many important physiological processes, including adipose differentiation, lipid and glucose metabolism, energy homoeostasis, cell proliferation, inflammation, reproduction and renoprotection [34], [35]. TZD prevented increase of TGF-Ī² and increase of ECM in cultured human mesangial cells [36], and both
Acknowledgments
This study was supported by a Grant from the Education Department of Heilongjiang Province (11551201), Youth Science Foundation of Heilongjiang Province (QC2010080) and National Natural Science Foundation of China (81100574).
References (42)
- et al.
Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database
Am. J. Kidney Dis.
(2012) - et al.
Progression of diabetic nephropathy
Kidney Int.
(2001) Diabetic nephropathy: prevention and treatment
Kidney Int.
(2001)- et al.
Diabetic cardiomyopathy
J. Card. Fail.
(2010) - et al.
Radical approach to diabetic nephropathy
Kidney Int. Suppl.
(2007) - et al.
Glycation induces formation of amyloid cross-beta structure in albumin
J. Biol. Chem.
(2003) - et al.
Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility
Kidney Int.
(1997) Microvascular complications of diabetes mellitus: renal protection accompanies cardiovascular protection
Am. J. Cardiol.
(2008)- et al.
Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury
Kidney Int.
(2004) - et al.
Pioglitazone attenuates TGF-beta(1)-induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator-activated receptor (PPAR)gamma
Cell Biol. Int.
(2005)
Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy
Cardiovasc. Ther.
Oxidative stress and diabetic complications
Circ. Res.
Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA
Diabetes Care
Skin collagen glycation, glycoxidation and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes control and complications trial
Diabetes
Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes
Diabetes
Lilly Lecture 1993. Glycation and diabetic complications
Diabetes
Advanced glycation end products, oxidative stress and diabetic nephropathy
Oxid. Med. Cell Longev.
Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions
J. Am. Soc. Nephrol.
Protein kinase C activation and its role in kidney disease
Nephrology
PKC-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase
J. Am. Soc. Nephrol.
New insights into the pathophysiology of diabetic nephropathy: from hemodynamics to molecular pathology
Eur. J. Clin. Invest.
Cited by (195)
Nrf2/HO-1 as a therapeutic target in renal fibrosis
2023, Life SciencesFerroptosis and ferritinophagy in diabetes complications
2022, Molecular MetabolismGlucose control, diabetic retinopathy, and hemodialysis induction in subjects with normo-microalbuminuric type 2 diabetic patients with normal renal function followed for 15 years
2022, Journal of Diabetes and its ComplicationsImprovement of E Se tea extracts on renal mesangial cell apoptosis and high-fat-diet/streptozotocin-induced diabetic nephropathy
2021, Journal of Functional FoodsThe potential of therapeutic strategies targeting mitochondrial biogenesis for the treatment of insulin resistance and type 2 diabetes mellitus
2024, Archives of Pharmacal ResearchPolyphenols target miRNAs as a therapeutic strategy for diabetic complications
2024, Critical Reviews in Food Science and Nutrition